Cite
APA Citation
Keam, B., Kim, T. M., Oh, D., Ock, C., Kang, W. K., Park, Y. H., Lee, J., Lee, J. H., Song, Y. J., & Park, Y. S. (n.d.). 288 A phase 1 study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors. Journal for immunotherapy of cancer, 8, A315. http://access.bl.uk/ark:/81055/vdc_100144711177.0x000005